Atlas Trials

Seaport Therapeutics

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Seaport Therapeutics

RecordFirmDate
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study) (NCT07161700)Seaport Therapeutics2025-09-02
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study) (NCT07065240)Seaport Therapeutics2025-06-19

Track Seaport Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.